XML 57 R11.htm IDEA: XBRL DOCUMENT

Accounts Receivable	12 Months Ended
Accounts Receivable	Dec. 31, 2019
Receivables [Abstract]
Accounts Receivable	Accounts Receivable As of December 31, 2019 the Company had accounts receivable of $7.2 million which relates to royalty revenue from sales of NARCAN®. At December 31, 2019 the Company's accounts receivable were primarily concentrated with one party, Adapt.